To be able to use the full range of Shopware 6, we recommend activating Javascript in your browser.

Welcome to JPT

My account

or sign up

Overview Account information Addresses Payment methods My orders

Your Cart
US$0.00

Products & Services

Clinical Conditions

Contract Research

Support & Contact

Peptide Pools

PepMix™ Peptide Pools

Control Pools

PepMix™ for Infectious Disease Antigens

PepMix™ for Tumor Associated Antigens

PepMix for other Antigens

Custom Peptide Pools

PepMix™ Collections

Pan Select PepMix™

Epitope Mapping Peptide Sets (EMPS)

PepSup™ Cell Activation Kit

SpotMix Antigen Discovery Pools

NeoSpikeMix for Immunopeptidomics

SpikeMix™ for Targeted Proteomics

Custom Peptides

Clinical Peptides

Peptide Libraries

PepTrack™ Peptide Libraries

Peptide ELISA

Positional Scanning Peptide Library

Proteomics Libraries & Kits

Absolute Quantified Peptides -SpikeTides™ TQL

SpikeTides™ Reference Peptides

Proteomics Standards & Controls

The Human Proteome Peptide Catalog

BioTides Biotinylated Peptides

Protein Interaction Screen on Peptide Matrix (PRISMA)

Protease Spots

Enzyme Substrate Sets

Assay Services

T Cell Assay Services

Enzyme Profiling Services

Antibody Assay Services

Peptide Arrays

PepStar™ Peptide Microarrays

PepStar™ for Infectious Diseases

PepStar™ for Tumor Associated Antigens

PepStar™ Antigen Collections

Custom PepStar™ Peptide Microarrays

PepStar™ Accessories

PepSpots Peptides on Cellulose

Enzyme Substrate Arrays

Application-specific Peptides

Antigen Peptides

Further Antigens

COVID-19 Antigens

Chelate DOTA Peptides

Sirtuin Substrates

Amyloid Beta A4 Peptides

Cosmetic DPRA Peptides

Peptide Conjugates

PTM Peptide Reference Standards

High Throughput Peptides

Quote Requests

Show all Products & Services

Cell Therapy & Vaccines

Tumor Antigen Vaccines

Cell Therapy Peptides

T Cell Epitope Discovery

Cellular Immune Monitoring

Humoral Immune Monitoring

B Cell Epitope Mapping

Neo-Epitopes

Neo-Epitope Prioritization

Neo-Epitope Therapy Development

Immune Monitoring

Immunology

Cellular Immune Responses

Humoral Immune Response

Proteomics

MS-based Proteomics

Functional Proteomics

Show all Research Areas

Infections

Monkeypox

SARS-CoV-2

Tropical Diseases

Coronaviruses

HIV

EBV

HCMV

HPV

Influenza

RSV

Antibody Services

Allergies

Alzheimers

Cancer

Autoimmune Diseases

Gene Therapy

Show all Clinical Conditions

Immunotherapy & Vaccines

Target Discovery & Epitope Discovery

Cell Therapy & Immunotherapy

Immune Monitoring

Bio- & Cheminformatics

Drug Discovery & Optimization

Peptide Discovery

Hit to Lead / Qualification

Peptide Optimization

Proteomics

MS-Based Proteomics

Functional Proteomics

Technologies & Know-How

Peptide Microarray-based Profiling

Peptide ELISA-based Validation

Mass Spectrometry-based Discovery

Medicinal Chemistry

Peptide Chemistry

Ultra High-Throughput Synthesis

Bioinformatics, Cheminformatics, Molecular Modeling

Project Management & Business Models

Projects

Chronic Fatigue Syndrome

DetectiVir

ProteomeTools

SARS-CoV-2 T Cell Immunity

SARS-CoV-2 B Cell Immunity

Peptide Mimotope Optimization

Show all Contract Research

Contact us

Resources

About Peptide Quality & Purity

Peptide Analysis Services

Peptide Delivery Formats

The World of PepMix

Peptide Library & Pool Design

PepSequencer

Application Protocols

Tutorials, Workshops & Seminars

FAQs

Publications & News

Press Releases & News

Applications Notes

Posters & Brochures

Conferences

References

References with Amyloid Beta Peptides

References with Antigen Peptides

References with BioTides Biotinylated Peptides

References with Custom Peptide Synthesis

References with PepSpots Peptides on Cellulose

References with SpotMix

References with PepMix™

References with PepMix™ Peptide Pools - Control Pools

References with PepMix™ Peptide Pools - Infectious Diseases

References with PepMix™ Peptide Pools - Tumor Associated Antigens

References with PepMix™ Peptide Pools - EMPS

References with PepMaster™

References with Clinical Peptides

References with Specialty Peptides

References with PepTrack™ Peptide Libraries

References with Proteomics Peptides

References with Absolute Quantified Peptides - SpikeTides™ TQL & SpikeTides™ TQL PLUS

References with Reference Peptides for Targeted Proteomics - SpikeTides™ & SpikeMix™

References with Protein Interaction Screen on Peptide Matrix (PRISMA)

References with NeospikeMix

References with Standards & Controls

References with Conjugates

References with Peptide ELISA

References with Enzyme Profiling Tools

References with Enzyme Substrate Sets

References with ProteaseSpots

References with Histone Code Tools

References with Enzyme Profiling - Assay Service

References with Enzyme Substrate Microarrays

References with PepStar™ Peptide Microarrays

References with Melanoma-associated peptides

Customer Testimonials

About Us

History

Team

Quality Management System

Partners & Collaborations

Corporate

Career

General Terms & Conditions

Privacy Policy

Imprint

Ordering, Payment & Shipping

Show all Support & Contact

Press Releases & News

Show all categories Back

Support & Contact

|

Publications & News

|

Press Releases & News

Press releases & news

Please have a look at our recent news or browse the archive.

News

22/03/2023

Will we see you at the next conference ?

09/03/2023

Get to Know the People at JPT!

02/03/2023

NEW: Monitor Immune Responses & Outbreaks with our PepMix Pan Selects!

15/02/2023

NEW: PepMix Peptide Pools for current SARS-CoV-2 variants

09/02/2023

Meet us at the Advanced Therapies Congress in London!

01/02/2023

This February: RSV Peptide Pools & Arrays 20% OFF

31/01/2023

Meet us at IO360° in New York

26/01/2023

INCOMING! New PepMix Peptide Pools for M. Tuberculosis!

19/01/2023

Visit the Whole Wide World of Peptide Pools

09/01/2023

The Fast & the Functional - High Throughput Custom Peptide Formats

1
2
3

Archive

07/12/2021

New AppNote Available: SARS-CoV-2 cross-reactivity upon infection & vaccination

27/10/2021

JPT’s peptides continue to contribute to important SARS-CoV-2 publications

14/10/2021

JPT Launches a New Website!

01/07/2021

NEW: Delta & Kappa SARS-CoV-2 PepMixes™

12/03/2021

NEW: SARS-CoV-2 PepMixes™ for Brazil, South Africa & California Mutations

24/02/2021

NEW: Virus-spanning PepMix™ Select Epitope Pools from JPT

04/02/2021

Identify Epitope Resolved Antibody Responses with SARS-CoV-2 Peptide Microarrays

27/01/2021

NEW Antigen Peptide Pools: SARS-CoV-2 B.1.1.7 (UK) & HCoV NCAP PepMixes™

29/12/2020

Have a Healthy New Year! 5 Things we are grateful for

15/12/2020

13 NEW Standardization Kits for MS based Neo-epitope Identification

09/12/2020

Study SARS CoV-2 Cross-Reactivity with MERS, SARS & Seasonal Coronaviruses

27/10/2020

What’s new in Neo-Epitope Discovery & Therapy?

15/10/2020

Infectious diseases beyond COVID-19 – JPT’s peptide formats in the literature

29/09/2020

Everything You Need to Know about Peptides

25/08/2020

JPT’s SARS CoV-2 Products Deliver Meaningful Results!

21/08/2020

SARS-COV-2 Spike & NCAP Mutations as PepMix™ Peptide Pools

31/07/2020

Study SARS CoV-2 Cross Reactive T-Cells with EMPS-Peptides from Endemic HCoV’s

15/07/2020

SARS COV-2 Mass Spec Reference Kit Released!

18/06/2020

JPT’s Innovation Featured on Cover of Proteomics Journal

11/06/2020

Mission Completed! Purified SARS-CoV-2 PepMixes™ & Peptide Arrays

15/05/2020

NEW: Additional SARS-CoV-2 PepMixes™ & Antigen Peptides

28/04/2020

New! SARS-CoV-2 Spike & NCAP Epitope Mapping Peptide Sets

02/04/2020

COVID-19: JPT receives status as Systemically Important Company

18/03/2020

NEW! SARS-CoV-2 PepMix™ Peptide Pools & Microarrays

09/03/2020

Measure T-Cell Clone Specificity with PepMaster™

04/03/2020

Peptide Pool Concepts from Discovery to the Clinic

04/02/2020

JPT Supports Immudex’ Annual Elispot Proficiency Panel 2020

01/01/2020

Our Highlights in 2019

09/10/2019

30 Years After The Wall: Eastern German Success Stories

20/08/2019

JPT turns 15!

03/07/2019

Boost Peptide Reliability with Peptide Analysis Services

05/06/2019

Have a look at Proteomics Publications using SpikeTides™ & Co.

21/05/2019

Are you going to FOCiS or BIO?

02/05/2019

Meet us at AAI, CIMT, Brisbane Immunotherapy & ISCT!

07/03/2019

NEW Cell Activation Kit: PepSup™

04/03/2019

JPT Maintains Quality Leadership - ISO 9001:2015 Recertification

09/02/2019

Free ELISPOT Workshops in Belgium & The Netherlands

02/05/2018

Superior Positive Control Pools for Better T-Cell Assays

05/04/2018

JPT launches The Human Proteome Peptide Catalog

11/11/2017

A New Peptide Approach to meet Antigen Sequence Diversity

07/11/2017

PROCAL - a new RT Standardization Kit for LC-MS based Proteomics

07/05/2009

TheraCode GmbH acquires JPT Peptide Technologies

Loading...

Check our list of products, click and go.

Stay in touch

Subscribe to our newsletter, issued approximately once a month. We don't just give you insights into our peptide synthesis systems, inform about our latest innovations and products, or provide an insider view into our company. We also send you recent publications and new developments in immunotherapy and proteomics.

All trademarks are owned by JPT Peptide Technologies GmbH and registered in Germany.

Quality Assurance
All production is performed according to ISO 9001:2015 standards

Support

Application Protocols
Career
Distributors
General Terms & Conditions
Imprint
Privacy policy
Press Releases & News
Ordering, Payment & Shipping

Contact

- JPT Peptide Technologies GmbH
- Volmerstrasse 5
- 12489 Berlin, Germany
- T: +49-30-6392-5500
- X: +49-30-6392-5501
- e-mail: info@jpt.com

- Technical Support:
- Worldwide
- T: +49-30-6392-7878
- X: +49-30-6392-7888
- e-mail: peptide@jpt.com
- North-America
- T: 1.888.JPT.COM0 (1.888.578.2660)
- X: 1.888.JPT.COM6 (1.888.578.2666)
- e-mail: peptide@jpt.com

Loading...

Copyright © 2021 | JPT Peptide Technologies